The U.S. Food and Drug Administration (FDA) has approved Merilog, a biosimilar to the widely used insulin product Novolog (insulin aspart), to enhance glycemic control in adults and children with ...

The FDA approved insulin-aspart-szjj (Merilog) as the first rapid-acting insulin biosimilar product to treat adults and children with diabetes, the agency announced Friday. Like its reference ...

(RTTNews) - The U.S. Food and Drug Administration announced that Sanofi-Aventis U.S. LLC's Merilog (insulin-aspart-szjj) becomes the first rapid-acting insulin biosimilar product to get its approval ...

Awiqli, the world's first weekly insulin, simplifies diabetes management by reducing daily injections while improving ...

Insulin remains one of the most important treatments for people living with diabetes. Whether someone has Type 1 diabetes or advanced Type 2 diabetes, insulin therapy helps control blood sugar levels, ...

Dr Anoop Misra and Dr Ambrish Mithal explain why insulin injections can't be replaced by a pill. Here is what happened to a ...

Please provide your email address to receive an email when new articles are posted on . Technsophere insulin conferred a similar HbA1c as a rapid-acting analog for children and adolescents with ...

India has become one of the first countries in the world to introduce Awiqli, the world's first once-a-week basal insulin ...

As a rapid-acting insulin, Merilog helps lower mealtime blood sugar spikes and improve blood sugar control in people with diabetes. The approval is for a 3 milliliter (mL) single-patient-use prefilled ...

Rapid-acting insulin. Works quickly for meals. Often more affordable than brand versions. People searching for common insulin brands often overlook generics. 4. Lyumjev (insulin lispro-aabc) Lyumjev ...

Merilog 100units/mL is supplied as both a 10mL multi-dose vial as well as a 3mL single-patient-use prefilled pen. The Food and Drug Administration (FDA) has approved Merilog (insulin-aspart-szjj), a ...

The U.S. Food and Drug Administration has approved Sanofi-Aventis's Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with diabetes mellitus.